by Karen Schroeder Kassel, MS, RD, MEd
Anakinra
(Kineret) is FDA-approved to treat adults with pain and swelling caused by moderate to severe active rheumatoid arthritis (RA) who have not found relief from other treatments.
Anakinra blocks the action of the protein interleukin-1 (IL-1). IL-1 is produced in excessive amounts in people with RA. High levels of IL-1 contribute to the joint pain, swelling, and stiffness of RA. By blocking IL-1, anakinra can help reduce these symptoms.
You may need to take anakinra for several weeks before your RA symptoms begin to improve.
Anakinra is given once a day as an injection. If you are prescribed anakinra, the doctor or nurse will teach you how to give yourself the injection so that you can do it at home.
The main side effect of this drug is mild redness, swelling, and pain at the injection site. Other side effects include:
Anakinra is not for everyone with RA. Talk to your doctor before taking anakinra if you:
If you are prescribed anakinra, there are other precautions that you should take, such as:
If you have tried other RA medicines and have not had any relief from your symptoms, talk to your doctor to find out if anakinra is a good option for you.
US Food and Drug Administration
http://www.fda.gov
Arthritis Foundation
http://www.arthritis.org/
The Arthritis Society
http://www.arthritis.ca/
Canadian Pharmacists Association
http://www.pharmacists.ca/
American Society of Health-System Pharmacists. Anakinra. PubMed Health website. Available at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000183. Updated February 1, 2009. Accessed September 12, 2012.
Anakinra (Kineret) FDA approved for use in rheumatoloid arthritis. American College of Rheumatology website. Available at: http://www.rheumat.... Updated November 2001. Accessed September 12, 2012.
Bresnihan, B, Alvara-Gracia, JM, Cobby, M, et al. Treatment of rheumatoid arthritis with recombinant human IL-1 receptor antagonist. Arthritis Rheum 1998; 41:2196.
Anakinra. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php. Updated December 14, 2011. Accessed September 12, 2012.
Fleischmann, RM, Schechtman, J, Bennett, R, et al. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial. Arthritis Rheum 2003; 48:927.
Patient information on anakinra. Austrailian Rheumatology Association website. Available at: http://www.rheumat.... Updated September 2011. Accessed September 12, 2012.
Last reviewed September 2012 by Brian Randall, MD
Last Updated: 9/12/2012
Copyright © 2013 EBSCO Publishing All rights reserved.
Sponsored by iHerb.Com
Positively the best overall value for natural products!